Previous Close | 99.60 |
Open | 101.69 |
Bid | 103.00 x 1400 |
Ask | 112.00 x 800 |
Day's Range | 97.95 - 103.82 |
52 Week Range | 88.05 - 180.06 |
Volume | |
Avg. Volume | 516,903 |
Market Cap | 4.329B |
Beta (5Y Monthly) | 0.02 |
PE Ratio (TTM) | 4.38 |
EPS (TTM) | 23.62 |
Earnings Date | Aug 03, 2022 - Aug 08, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 160.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for QDEL
SAN DIEGO, May 27, 2022--QuidelOrtho Corporation (NASDAQ: QDEL) ("QuidelOrtho") announced completion of the transaction combining Quidel Corporation ("Quidel") and Ortho Clinical Diagnostics Holdings plc ("Ortho"), creating QuidelOrtho, a leading in vitro diagnostics company. The new company, headquartered in San Diego, California, generated more than $3.5 billion in combined revenues in 2021 and has approximately 6,000 employees. QuidelOrtho will trade on the Nasdaq Global Select Market under t
SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, and Ortho Clinical Diagnostics Holdings plc (“Ortho”), one of the world’s larger pure-play in vitro diagnostics companies, announced today that the closing of the previously announced Ortho transaction is expected to occur on May 27, 2022. On May 26, 2022, the High Court of Justice of England a
These are the healthcare stocks with the best value, fastest growth, and most momentum for June 2022.